Patent Open Access
Alkoclar, Erdal Can; Yesil, Metehan
{ "inLanguage": { "alternateName": "eng", "@type": "Language", "name": "English" }, "description": "<p>A bioceutical formulation consisting of RNA Polymerase inhibiting and immunomodulatory features- exhibiting Glucopyranoside Analouges for the Adjunctive Treatment of Emerging Covid-19 Subvariants.</p>\n\n<p> </p>\n\n<p>Inventors: Erdal Can Alkoclar & Metehan Yesil</p>", "creator": [ { "affiliation": "Mas Pharmaceuticals", "@type": "Person", "name": "Alkoclar, Erdal Can" }, { "@type": "Person", "name": "Yesil, Metehan" } ], "url": "https://sciencerepository.dk/record/24", "datePublished": "2022-07-08", "version": "1.0", "keywords": [ "Omicron covid-19" ], "@context": "https://schema.org/", "identifier": "https://doi.org/10.82163/sciencerepository.24", "@id": "https://doi.org/10.82163/sciencerepository.24", "@type": "CreativeWork", "name": "An Antiviral Formulation with RNA Dependent RNA Polymerase & DNA Gyrase Suppressive Properties for the Treatment of Emerging Covid-19 Subvariants" }
All versions | This version | |
---|---|---|
Views | 0 | 0 |
Downloads | 0 | 0 |
Data volume | 0 Bytes | 0 Bytes |
Unique views | 0 | 0 |
Unique downloads | 0 | 0 |